Ocular surface disease index in Graves’ orbitopathy: a cross-sectional study

Ocular surface disease index in Graves’ orbitopathy: a cross-sectional study

IntroductionGraves' Orbitopathy (GO) is an autoimmune disorder characterized by inflammation of orbital tissues, leading to various ocular manifestations, including ocular surface disease. This cross-sectional study aimed to assess the presence of ocular surface disease using the Ocular Surface...

Full description

Saved in:

Bibliographic Details
Main Authors:	Maria Novella Maglionico, Giulia Lanzolla, Michele Figus, Giada Cosentino, Simone Comi, Michele Marinò, Ferruccio Santini, Chiara Posarelli
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-12-01
Series:	Frontiers in Endocrinology
Subjects:	Graves’ orbitopathy Graves’ disease dry eye disease thyroid autoimmunity ocular surface disease ocular surface disease index
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2024.1428185/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Role of genetics and epigenetics in Graves’ orbitopathy
by: Michele Marinò, et al.
Published: (2024-11-01)

Incidence and risk factors for Graves’ orbitopathy in patients who underwent anti-inflammatory and immunosuppressive treatment during medical treatment for Graves’ disease: investigation of 1,553 cases with newly diagnosed Graves’ disease and proposal of a predictive score
by: Natsuko Watanabe, et al.
Published: (2023-11-01)

Incidence of the postpartum diagnosis of thyroid eye disease in relation to thyroid function in Graves’ disease
by: Nami Suzuki, et al.
Published: (2025-01-01)

Therapeutic effect of selective interleukin-2-inducible tyrosine kinase inhibitor in orbital fibroblasts from patients with Graves’ orbitopathy
by: Yeonjung Yoon, et al.
Published: (2024-09-01)

Selenium and Graves’ Disease
by: Vahab Fatourechi, et al.
Published: (2024-10-01)

Changes of plasma cytokines content in Graves’ orbitopathy patients, could be potential markers
by: Ying Fu, et al.
Published: (2024-04-01)

Application of lacrimal gland ultrasonography in the evaluation of chronic ocular graft-versus-host-disease
by: Mingxia Zhong, et al.
Published: (2025-02-01)

Deep learning-based CNN for multiclassification of ocular diseases using transfer learning
by: G Divya Deepak, et al.
Published: (2024-12-01)

Evaluation of ocular surface temperature in post-COVID-19 patients with different degrees of fever via infrared thermal imaging
by: Chunbo Wu, et al.
Published: (2025-01-01)

Evaluation of ocular surface inflammation and systemic conditions in patients with systemic lupus erythematosus: a cross-sectional study
by: Yuerong Ren, et al.
Published: (2024-11-01)

The relationship between cholesterol levels and thyroid eye disease
by: Caroline Cardo, et al.
Published: (2025-02-01)

Management of Graves’ upper eyelid retraction (GUER): A review
by: Akruti Desai, et al.
Published: (2025-02-01)

Evans syndrome and Graves' Disease: An unusual presentation – A case report
by: Amtoj Singh Lamba, et al.
Published: (2022-01-01)

Impact of COVID-19 on thyroid gland functions with reference to Graves’ disease: A systematic review
by: I. S. Vamshidhar, et al.
Published: (2023-09-01)

Updates in the Management of Graves Disease in Children
by: Yun Jeong Lee
Published: (2023-12-01)

Prevalence of dry eye disease in rheumatoid arthritis patients and its correlation with duration of rheumatoid arthritis
by: Priyanshi Ashishbhai Gandhi, et al.
Published: (2024-12-01)

Influencing factors of ocular pain in dry eye disease patients at high altitude
by: Peng-Cheng Zhang, et al.
Published: (2024-12-01)

Case series of dermopathy in autoimmune thyroid disease
by: Janić Tamara, et al.
Published: (2024-01-01)

Causal association between non-thyroidal autoimmune diseases and Graves' ophthalmopathy: A mendelian randomization study
by: Lan Ma, et al.
Published: (2025-02-01)

Study on the correlation between serum IgG4/IgG levels and the development of Graves’ ophthalmopathy
by: Yuanyuan Deng, et al.
Published: (2025-01-01)

Genetic and Plasma Proteomic Approaches to Identify Therapeutic Targets for Graves’ Disease and Graves’ Ophthalmopathy
by: Ke C, et al.
Published: (2025-02-01)

Knowledge and awareness of ocular allergy among undergraduate students at a public university in Riyadh, Saudi Arabia
by: Khalid Bin Abdulrahman, et al.
Published: (2024-11-01)

SMILE and ICL implantation on the ocular surface and meibomian glands in patients with postoperative myopia
by: Juan Yao, et al.
Published: (2024-12-01)

Ocular Surface Disease and Dry Eye Severity in Glaucoma Patients at Urban Private Eye Care Centres in Malaysia
by: Gan EH, et al.
Published: (2024-11-01)

Correlation between the Ocular Surface Disease Index and dry eye functional parameters measured with the OCULUS Keratograph 5M in a Hispanic population
by: Nallely R. Morales-Mancillas, et al.
Published: (2024-10-01)

Graves’ hyperthyroidism treated with potassium iodide: early response and after 2 years of follow-up
by: Megumi Fujikawa, et al.
Published: (2024-11-01)

Evaluating the patient's serum for thyroid stimulating immunoglobulin and Cytotoxic -T-lymphocyte associated protein 4 in Graves hyperthyroidism
by: Alkhansaa Tariq, et al.
Published: (2024-12-01)

Comparing the corneal temperature of dry eyes with that of normal eyes via high-resolution infrared thermography
by: Chunbo Wu, et al.
Published: (2025-01-01)

How to Fabricate Hyaluronic Acid for Ocular Drug Delivery
by: Martha Kim, et al.
Published: (2024-12-01)

Systemic Treatment with the Janus Kinase Inhibitor Baricitinib in Ocular Chronic Graft-versus-Host Disease
by: Taylor McManus, BS, MS, et al.
Published: (2025-01-01)

Thyroid Storm in the Heart: Graves’ Disease Masquerading as Dilated Cardiomyopathy in an Elderly Male
by: Susheel K. Malani, et al.
Published: (2024-12-01)

Acute Lymphoblastic Leukemia in an Adolescent Girl with Graves’ Disease: A Coincidence or Consequence
by: Ghassan Faisal Fadlalbari, et al.
Published: (2023-01-01)

A Belgian single centre outcome study of radioiodine treatment in adolescents with Graves’ disease
by: Laura Chielens, et al.
Published: (2024-12-01)

Predictive factors influencing hypothyroidism following the radioactive iodine treatment of Graves’ disease in different periods
by: Aomei Zhao, et al.
Published: (2024-12-01)

The role of autophagy in Graves disease: knowns and unknowns
by: Hayder M. Al-kuraishy, et al.
Published: (2025-01-01)

A proliferation-inducing ligand (APRIL) level among risk factors of ocular involvement in patients with Behçet’s disease
by: Rasha M. Ghaleb, et al.
Published: (2024-11-01)

Effects of Glaucoma Treatment on Ocular Surface and Tear Functions: Comparison of Trabeculectomy and Antiglaucoma Drops
by: Abdussamet Mermer, et al.
Published: (2024-10-01)

Effect of micronutrients on the risk of Graves’ disease: a Mendelian randomization study
by: Fangsen Chen, et al.
Published: (2024-12-01)

Association between allergic rhinitis and development of autoimmune thyroid diseases in Egyptian patients
by: Magdy Mohamed Allam, et al.
Published: (2024-12-01)

Single-cell transcriptomics in thyroid eye disease
by: Sofia Ahsanuddin, et al.
Published: (2024-12-01)